Navigation Links
ProActive Remedies, LLC Announces Launch of New Allergy Medication

WINDSOR, Colo., March 27 /PRNewswire/ -- A new patent-pending allergy medication and treatment method is available over the counter as an alternative to allergy shots. ProActive Remedies, LLC announced today that it has begun selling ALLERTHERAPY for the treatment of allergies. The oral immunotherapy spray helps allergy sufferers by building immunity to a wide variety of targeted allergens through the administration of low homeopathic concentrations of such allergens. Over time, this treatment may save money for allergy sufferers through decreased doctor visits, absences, medications, and complications by reducing allergic reactions. ProActive Remedies, LLC sells directly to allergy sufferers through its online store at

To date, ProActive Remedies, LLC has brought to market the ALLERTHERAPY Pollen Mix medication, and anticipates releasing food, environment, and combination mixes this spring. ProActive Remedies, LLC's ALLERTHERAPY line offers an assortment of features including multi-regional, multi-seasonal formulas, a wide variety of targeted allergens, reduced dependence upon allergy medications -- including ALLERTHERAPY itself -- over time, and a 30 Day Unconditional Guarantee. Treatment can reduce the severity of allergic reactions by fifty percent or more. This translates into substantial future savings. Additional benefits to allergy sufferers are the improvements in lifestyle that come with increased allergen tolerance. Improved indoor and outdoor comfort, improved tolerance of pets, and the ability to widen the variety of foods in the food allergy sufferer's diet are among the advantageous results of the ALLERTHERAPY Treatment Method.

According to American Academy of Allergy Asthma & Immunology (AAAAI) estimates, more than twenty percent of Americans are affected by allergic diseases. These allergic diseases are the sixth leading cause of chronic diseases in Americans. In 1996, allergic rhinitis was estimated to have an overall cost of $6 billion in the U.S. The AAAAI also notes that up to 90 percent of those with seasonal allergic rhinitis and up to 80 percent of those with perennial allergic rhinitis are able to successfully treat their condition with immunotherapy. Not all patients qualify for allergy shots, or are able to commit to the rigorous schedule of appointments. The ALLERTHERAPY line of liquid immunotherapy spray is simple to administer and available over the counter as an alternative treatment option. Those with serious allergies or other medical conditions should use ALLERTHERAPY under doctor supervision only. For more information about ALLERTHERAPY, please visit the website at Orders may be placed online or by calling 1 (877) GO-ALLER or 1 (877) 462-5537.

For additional information, contact:

Contact Person: Connie Williams

Company: ProActive Remedies, LLC

Phone: (800) 874-0989 ext. 300

Fax: (703) 637-9893



Phone Orders: (877) GO-ALLER / (877) 462-5537

ProActive Remedies, LLC is dedicated to developing products that empower consumers. The company conducts extensive research to define consumer needs and to develop and market cutting-edge products. The release of ALLERTHERAPY is the result of this process.

This release was issued through eReleases(TM). For more information, visit

SOURCE ProActive Remedies, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Virginia School District Gets Proactive Against MRSA
2. Cancer care providers need to proactively address patients psychological and social needs
3. BJs Charitable Foundation Announces Q4 Donation of More Than $500,000 to Programs That Benefit Children and Families
4. Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770
5. ThalesNano Announces the Launch of X-Cube Flash(TM), its Next Generation High Temperature and Pressure Continuous Process Reactor
6. Laureate Announces Second Manufacturing Agreement with Cytheris
7. China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results
8. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
9. FEW Announces Legislative Goals for Remainder of 110th Congress; Delivers Fact Sheets to Legislators
10. Hillenbrand Industries, Inc. Announces Pricing of Its Pending Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009
11. EnergyNow! Announces New Grant Funding to Combat Childhood Obesity
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family ... tests directly from their electronic medical record (EMR) without the need for redundant ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., ... the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by ... through Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... all, Water For Empowerment ™ attracts volunteers together who want to combine ... empowering women as key stakeholders in the process. The non-profit launched its first ...
(Date:11/25/2015)... NV (PRWEB) , ... November 25, 2015 , ... Dr. ... patients to learn more about hair loss treatment with the Capillus272™ Pro laser therapy ... effective solution for thicker and fuller hair, without the need for surgery, prescription pills, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, ... country to celebrate their sobriety and show through pictures what a positive difference ... photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Nederland, November 26, 2015 ... Een nieuwe aanpak combineert immunotherapie met ... kanker. ) ...      (Photo: ) ... Leids Universitair Medisch Centrum (LUMC) ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Japanese therapeutic drug monitoring market, ...
(Date:11/26/2015)... --> ... att använda SyMRI för att hitta optimal ... med multipel skleros (MS) eller hjärntumörmetastaser och ... för att kunna använda SyMRI Research Edition ... kan man generera flera konstrastbilder från en ...
Breaking Medicine Technology: